Literature DB >> 17694387

Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration.

Kamilla Miskowiak, Becky Inkster, Sudhakar Selvaraj, Guy Goodwin, Catherine Harmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17694387     DOI： 10.1007/s00213-007-0907-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  13 in total

1.  Automated Talairach atlas labels for functional brain mapping.

Authors:  J L Lancaster; M G Woldorff; L M Parsons; M Liotti; C S Freitas; L Rainey; P V Kochunov; D Nickerson; S A Mikiten; P T Fox
Journal:  Hum Brain Mapp       Date:  2000-07       Impact factor: 5.038

2.  Spatial performance and corticosteroid receptor status in the 21-day restraint stress paradigm.

Authors:  Efthimia Kitraki; Olympia Kremmyda; Dionyssios Youlatos; Michalis Alexis; Christos Kittas
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

Review 3.  Adult neurogenesis and functional plasticity in neuronal circuits.

Authors:  Pierre-Marie Lledo; Mariana Alonso; Matthew S Grubb
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

4.  Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor.

Authors:  Barbara Viviani; Stefano Bartesaghi; Emanuela Corsini; Pia Villa; Pietro Ghezzi; Angela Garau; Corrado L Galli; Marina Marinovich
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

Review 5.  Emerging biological roles for erythropoietin in the nervous system.

Authors:  Michael Brines; Anthony Cerami
Journal:  Nat Rev Neurosci       Date:  2005-06       Impact factor: 34.870

6.  Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin.

Authors:  H Ehrenreich; D Hinze-Selch; S Stawicki; C Aust; S Knolle-Veentjer; S Wilms; G Heinz; S Erdag; H Jahn; D Degner; M Ritzen; A Mohr; M Wagner; U Schneider; M Bohn; M Huber; A Czernik; T Pollmächer; W Maier; A-L Sirén; J Klosterkötter; P Falkai; E Rüther; J B Aldenhoff; H Krampe
Journal:  Mol Psychiatry       Date:  2006-10-10       Impact factor: 15.992

7.  Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance.

Authors:  Ahmad R Hariri; Terry E Goldberg; Venkata S Mattay; Bhaskar S Kolachana; Joseph H Callicott; Michael F Egan; Daniel R Weinberger
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

8.  Erythropoietin enhances hippocampal response during memory retrieval in humans.

Authors:  Kamilla Miskowiak; Ursula O'Sullivan; Catherine J Harmer
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

9.  Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis.

Authors:  Mark I Ransome; Ann M Turnley
Journal:  J Neurochem       Date:  2007-06-07       Impact factor: 5.372

10.  Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.

Authors:  Luca Santarelli; Michael Saxe; Cornelius Gross; Alexandre Surget; Fortunato Battaglia; Stephanie Dulawa; Noelia Weisstaub; James Lee; Ronald Duman; Ottavio Arancio; Catherine Belzung; René Hen
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728
View more
  4 in total

Review 1.  Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal:  Psychopharmacology (Berl)       Date:  2011-09-23       Impact factor: 4.530

2.  Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Ellen M Christensen; Jens D Bukh; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal:  Neuropsychopharmacology       Date:  2013-12-10       Impact factor: 7.853

3.  Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.

Authors:  Kamilla Miskowiak; Becky Inkster; Ursula O'Sullivan; Sudhakar Selvaraj; Guy M Goodwin; Catherine J Harmer
Journal:  Exp Brain Res       Date:  2007-09-08       Impact factor: 1.972

4.  Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.

Authors:  Michael Brines; Nimesh S A Patel; Pia Villa; Courtenay Brines; Tiziana Mennini; Massimiliano De Paola; Zubeyde Erbayraktar; Serhat Erbayraktar; Bruno Sepodes; Christoph Thiemermann; Pietro Ghezzi; Michael Yamin; Carla C Hand; Qiao-wen Xie; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-01       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.